Mumbai-based valve manufacturer Dembla Valves Ltd has raised equity funding from a clutch of investors and is aiming to ...
The closing of the Offering is expected to occur on or about February 7, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offering are expected to be ...
MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical ...
By raising ₹500-600 crore, this firm aims to strengthen its market position and adapt to evolving global trends.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
MicroStrategy has announced the pricing of its strike preferred stock offering as the company continues to finance Bitcoin ...